Dibenzepin
- Level
- Commodity
- Parent
- 51292900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292916This classification denotes a dibenzazepine and tricyclic antidepressive agent with the molecular formula C18H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 510SJZ1Y6L, chemically known as 5,10-dihydro-10-(2-(dimethylamino)ethyl)-5-methyl-11h-dibenzo(b,e)(1,4)diazepin-11-one but generally known as dibenzepin, which bears US NIH Compound Identifier 9419. European Medicines Agency schedules Dibenzepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07074MIG. World Health Organization schedules dibenzepin in its Anatomical Therapeutic Chemical (ATC) Classification. DIBENZEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dibenzepin under HS 29339940 and SITC 51577. As of Q4 2014, DIBENZEPIN remains the US FDA Preferred Term for this commodity. SMILES: O=C1N(CCN(C)C)C2C(N(C3C1CCCC3)C)CCCC2.
Same parent
Under 51292900 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.